Tag: Hannah L. Robbins

  • Nation & World

    New vista for brain disorder research

    For the first time, researchers describe the types of cells generated in brain organoids, networks of nerve cells, and show the greater diversity, complexity, and response to stimulation developed for nine months and longer.

    5 minutes
  • Nation & World

    Compound protects nerve cells targeted by diseases

    Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.

    5 minutes
  • Nation & World

    Progress in treating hearing loss

    Harvard Stem Cell Institute researchers have developed a drug cocktail that unlocks the potential to regrow inner-ear hair cells, which could help combat hearing loss.

    4 minutes
  • Nation & World

    Medical hope on horizon

    Stem cell science is accelerating development of therapies for diabetes, ALS, other diseases, researchers tell HUBweek sessions.

    9 minutes
  • Nation & World

    Progress against acute myeloid leukemia

    A new drug compound developed by researchers at Massachusetts General Hospital and the Harvard Stem Cell Institute to treat acute myeloid leukemia is gentle enough to use with patients too frail to endure chemotherapy.

    3 minutes
  • Nation & World

    New weapon against breast cancer

    Levels of a molecular marker in healthy breast tissue can predict a woman’s risk of getting cancer, according to new research from the Harvard Stem Cell Institute.

    3 minutes
  • Nation & World

    Brains or skin?

    A protein that is necessary for the formation of the vertebrate brain has been identified by researchers at the Harvard Stem Cell Institute (HSCI) and Boston Children’s Hospital, in collaboration with scientists from Oxford and Rio de Janeiro.

    2 minutes